M3 将来の成長

Future 基準チェック /26

M3利益と収益がそれぞれ年間10.6%と9.1%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に14.1% 10.4%なると予測されています。

主要情報

10.6%

収益成長率

10.4%

EPS成長率

Healthcare Services 収益成長	0%
収益成長率	9.1%
将来の株主資本利益率	14.1%
アナリストカバレッジ	Good
最終更新日	30 Jul 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

BMV:2413 N - アナリストの将来予測と過去の財務データ ( )JPY Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2027	323,358	58,991	51,001	N/A	12
3/31/2026	293,962	52,898	45,279	N/A	13
3/31/2025	266,816	47,539	38,502	N/A	13
6/30/2024	245,696	44,105	N/A	N/A	N/A
3/31/2024	238,883	45,271	50,729	58,310	N/A
12/31/2023	234,852	46,363	48,074	59,340	N/A
9/30/2023	233,997	48,374	48,074	58,719	N/A
6/30/2023	231,218	49,315	49,924	59,680	N/A
3/31/2023	230,818	49,028	49,536	57,113	N/A
12/31/2022	229,145	46,955	49,787	54,523	N/A
9/30/2022	223,128	47,117	54,609	58,728	N/A
6/30/2022	218,752	60,203	49,565	53,415	N/A
3/31/2022	208,159	63,845	48,891	52,108	N/A
12/31/2021	199,617	67,280	46,178	48,867	N/A
9/30/2021	191,823	63,900	44,517	46,894	N/A
6/30/2021	180,123	47,124	45,531	47,375	N/A
3/31/2021	169,198	37,822	44,638	46,627	N/A
12/31/2020	158,404	31,760	38,205	40,464	N/A
9/30/2020	144,450	26,520	31,617	34,196	N/A
6/30/2020	135,685	23,190	26,405	29,364	N/A
3/31/2020	130,973	21,635	23,949	26,789	N/A
12/31/2019	125,704	21,589	23,863	26,246	N/A
9/30/2019	121,329	20,887	17,971	19,995	N/A
6/30/2019	116,927	19,865	17,924	19,463	N/A
3/31/2019	113,059	19,577	16,404	17,749	N/A
12/31/2018	109,585	19,532	12,206	13,931	N/A
9/30/2018	104,897	19,796	14,624	16,717	N/A
6/30/2018	99,495	19,580	13,898	15,908	N/A
3/31/2018	94,471	19,684	N/A	15,913	N/A
12/31/2017	90,402	18,934	N/A	16,314	N/A
9/30/2017	86,118	17,830	N/A	17,543	N/A
6/30/2017	81,960	17,303	N/A	17,382	N/A
3/31/2017	78,143	16,004	N/A	16,555	N/A
12/31/2016	73,570	14,871	N/A	14,848	N/A
9/30/2016	69,009	13,526	N/A	14,631	N/A
6/30/2016	67,189	12,953	N/A	13,813	N/A
3/31/2016	64,660	12,508	N/A	12,136	N/A
12/31/2015	60,288	11,664	N/A	10,106	N/A
9/30/2015	57,241	10,874	N/A	9,879	N/A
6/30/2015	54,598	10,486	N/A	8,931	N/A
3/31/2015	51,346	9,759	N/A	9,316	N/A
12/31/2014	48,687	9,740	N/A	9,085	N/A
9/30/2014	44,767	9,236	N/A	9,205	N/A
6/30/2014	40,966	8,838	N/A	8,714	N/A
3/31/2014	36,887	8,318	N/A	8,647	N/A
12/31/2013	33,967	7,409	N/A	7,483	N/A
9/30/2013	31,379	6,505	N/A	6,626	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 2413 Nの予測収益成長率 (年間10.6% ) は貯蓄率 ( 7.9% ) を上回っています。

収益対市場: 2413 Nの収益 ( 10.6% ) MX市場 ( 11.4% ) よりも低い成長が予測されています。

高成長収益: 2413 Nの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: 2413 Nの収益 ( 9.1% ) MX市場 ( 7.2% ) よりも速いペースで成長すると予測されています。

高い収益成長: 2413 Nの収益 ( 9.1% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 2413 Nの自己資本利益率は、3年後には低くなると予測されています ( 14.1 %)。

M3 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

M3, Inc. Provides Consolidated Earnings Guidance for the Full Fiscal Year Ending March 31, 2024

M3, Inc. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and the Full Year Ending March 31, 2024

Recent updates

M3, Inc. to Report Q2, 2025 Results on Oct 30, 2024

M3, Inc. to Report Q1, 2025 Results on Jul 26, 2024

Less than half of directors are independent

M3, Inc., Annual General Meeting, Jun 26, 2024

M3, Inc. to Report Fiscal Year 2024 Results on Apr 26, 2024

M3, Inc. to Report Q3, 2024 Results on Jan 31, 2024

M3, Inc. (TSE:2413) entered into a share tender agreement to acquire a 55% stake in Benefit One Inc. (TSE:2412) from Pasona Group Inc. (TSE:2168) and others for approximately ¥140 billion.

M3, Inc. Provides Consolidated Earnings Guidance for the Full Fiscal Year Ending March 31, 2024

Less than half of directors are independent

M3, Inc. to Report Q2, 2024 Results on Oct 27, 2023

M3, Inc. (TSE:2413) acquired Messly Limited.

M3, Inc. (TSE:2413) acquired frogwell corporation.

M3, Inc. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and the Full Year Ending March 31, 2024

No independent directors

M3, Inc. to Report Q1, 2024 Results on Jul 28, 2023

Upcoming dividend of JP¥19.00 per share at 0.5% yield

Third quarter 2023 earnings released: EPS: JP¥22.42 (vs JP¥22.66 in 3Q 2022)

M3, Inc. (TSE:2413) acquired Michael Allen Company.

M3, Inc. to Report Q3, 2023 Results on Feb 03, 2023

Second quarter 2023 earnings released: EPS: JP¥17.58 (vs JP¥36.86 in 2Q 2022)

No independent directors

Second quarter 2023 earnings released: EPS: JP¥18.38 (vs JP¥36.86 in 2Q 2022)

M3, Inc. (TSE:2413) acquired Rinkai Medical Service.

M3, Inc. to Report Q2, 2023 Results on Nov 02, 2022

First quarter 2023 earnings released: EPS: JP¥19.87 (vs JP¥23.23 in 1Q 2022)

No independent directors

M3, Inc. (TSE:2413) acquired Edoctores Soluciones.

No independent directors

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘